“Real-world data on the incidence of immune-related adverse events associated with anti-PD-1/PD-L1 treatment in Russia”, Вопр. онкол., vol. 68, no. 2, pp. 188–199, May 2022, doi: 10.37469/0507-3758-2022-68-2-188-199.